The American Academy of Ophthalmology has published several dosing and screening recommendations for hydroxychloroquine to avoid potential retinal toxicity, yet some patients still experience permanent vision loss resulting from hydroxychloroquine retinopathy due to improper dosing of the drug and improper screening.
A cookie-cutter approach to dosing Plaquenil (hydroxychloroquine, Sanofi-Aventis), an anti-malarial drug that has been used as a treatment for systemic lupus erythematosus and rheumatoid arthritis, by rheumatologists and internal medicine doctors can lead to an increased risk for
Uncategorized